jaundice
[용어속성] Term
Exacerbation of Secondary Cold Agglutinin Syndrome in the Setting of SARS-CoV-2
Internal Medicine
[키워드] acute respiratory syndrome
Agglutinin
autoimmune hemolytic anemia (aiha)
CAS
Cold
cold agglutinin syndrome
coronavirus
Coronavirus 2019
cough
covid coagulopathy
covid hypercoagulability
COVID-19
COVID-19 associated coagulopathy
COVID-19 pneumonia
dexamethasone 6 mg
elevated
Exacerbation
female
FIVE
hemoglobin
hemolytic anemia
Infection
initiated
jaundice
laboratory investigation
nasal swab
Pneumonia
positive
Remdesivir
resulting
RT-PCR
SARS-CoV-2
secondary
setting
Seven
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Shortness of breath
syndrome
the patient
total bilirubin
transfusion in covid 19 pandemic
Treatment
Urine
WBC
White blood cell
worsening
[DOI] 10.7759/cureus.19387 PMC 바로가기 [Article Type] Internal Medicine
[DOI] 10.7759/cureus.19387 PMC 바로가기 [Article Type] Internal Medicine
Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19
중증 코로나19 환자에서 지속 황달의 원인인 이차성 경화성 담관염
Article
Published on
Journal: Liver international : official journal of the Inte [Category] MERS, SARS, 변종, 진단,
Journal: Liver international : official journal of the Inte [Category] MERS, SARS, 변종, 진단,
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
analysed
Analysis
bile ducts
Cholangitis
cholestasis
Cohort
conducted
consecutive patient
coronavirus
coronavirus disease
coronavirus disease 19
Coronavirus disease 19 (COVID-19)
COVID-19
COVID-19 patient
Critically ill
critically ill COVID-19 patients
Critically ill patient
critically ill patients
diagnostic
disease course
group
had no
histopathological finding
histopathological findings
ICU
indicated
Influenza
influenza A
Injury
intensive care
intensive care unit
IQR
jaundice
liver
Liver injury
median
Mild
morbidity and mortality
Occurrence
pandemic
Patient
patients
radiological
respiratory
retrospective
retrospective cohort
SARS-CoV-2
sclerosing cholangitis
sclerosing cholangitis in critically ill patients
secondary
secondary sclerosing cholangitis
serological
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
severe COVID-19
significantly
SSC
university
variant
[DOI] 10.1111/liv.14971 PMC 바로가기 [Article Type] Article
[DOI] 10.1111/liv.14971 PMC 바로가기 [Article Type] Article
Case report: hepatitis in a child infected with SARS-CoV-2 presenting toll-like receptor 7 Gln11Leu single nucleotide polymorphism
사례보고 : SARS-COV-2에 감염된 아동의 간염이 통료 유사 수용체 7 GLN11LEU 단일 뉴클레오티드 다형성을 나타냅니다.
Case Reports
[키워드] acholic stool
Alanine
alanine aminotransferase
alkaline phosphatase
aspartate
Aspartate aminotransferase
Bilirubin
C-reactive protein
caused
characterized
Child
children
COVID-19
cytomegalovirus
D-dimer
deficiency
Diseases
drug
dry cough
Dyspnea
Epstein–Barr virus
Fever
form
Gastrointestinal symptom
gastrointestinal symptoms
gastrointestinal tract
Genes
Hepatitis
hepatitis A
hepatotoxic
HIV
Host
IgA
IgG
immune
immune deficiency
immune response
impair
IMPROVE
infected with SARS-CoV-2
Infection
Infectious diseases
Influenza
influenza A
ingestion
initial
Innate immune defense
innate immune system
Innate immunity
interview
investigated
jaundice
knowledge
liver
male
male child
MCP-1
medications
monocyte
monocyte chemoattractant protein-1
Mutation
Non-synonymous
nucleotide
organ
organs
PAMPs
pathogen
pathogen-associated molecular pattern
pathogen-associated molecular patterns
Patient
Pattern recognition
pattern recognition receptor
phenotype
phosphatase
Pneumonia
polymorphism
Polymorphisms
positive
presenting
Protein
PRRs
recognize
recognizing
reported
respiratory
respiratory tract
rs 179008
RSV
SARS-CoV-2
SARS-CoV-2 IgM
serological test
Serological tests
several genes
single nucleotide
Single nucleotide polymorphism
SNP
ssRNA
Stool
the patient
tirap
tlr-3
TLR-7
TLR3
Toll-like receptor
toll-like receptor 7
Toll-like receptor 7 Gln11Leu
Treatment
virus
[DOI] 10.1186/s12985-021-01656-3 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1186/s12985-021-01656-3 PMC 바로가기 [Article Type] Case Reports
COVID-19: a fatal case of acute liver failure associated with SARS-CoV-2 infection in pre-existing liver cirrhosis
COVID-19 : 기존 간경변에서 SARS-COV-2 감염과 관련된 급성 간부전의 치명적인 경우
Case Reports
[키워드] accompanied
ACE2
acute hepatitis
acute liver failure
acute respiratory syndrome
acute respiratory syndrome coronavirus
angiotensin
Angiotensin-converting enzyme
angiotensin-converting enzyme-2
Autopsy
Bile duct
Case report
cathepsin
cathepsin L
clinical setting
Clinical sign
Clinical signs
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
debate
died
differential diagnosis
enzyme
Evidence
expression
Hepatitis
human tissues
jaundice
liver
Liver cirrhosis
Liver damage
liver failure
non-respiratory tissues
Pneumonia
Post-mortem
respiratory
SARS-CoV-2
SARS-COV-2 infection
Serine
severe acute respiratory syndrome Coronavirus
susceptibility
TMPRSS2
transmembrane serine protease
transmembrane serine protease 2
Viral
viral infection
Viremia
women
[DOI] 10.1186/s12879-021-06605-7 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1186/s12879-021-06605-7 PMC 바로가기 [Article Type] Case Reports
Jaundice in patients with COVID ‐19
Original Article
Published on
Journal: JGH Open: An Open Access Journal of Gastroenterology and Hepatology [Category] COVID-19,
Journal: JGH Open: An Open Access Journal of Gastroenterology and Hepatology [Category] COVID-19,
[키워드] activities
addressed
Admission
alanine aminotransferase
alkaline phosphatase
analyzed
Bilirubin
Care
characterized
clinical consequence
Clinical features
Concentration
coronavirus disease
COVID
COVID‐19
COVID‐19
defined
determine
elevated
etiology
Fever
Frequency
hallmark
hepatic
Hepatitis
hepatocellular
high mortality
Hospitalized
Hypoxemia
Injury
intensive care
Invasive mechanical ventilation
jaundice
laboratory abnormalities
Leukocytosis
leukopenia
liver
liver dysfunction
Liver injury
mortality rate
Patient
procalcitonin
reported
Result
Sepsis
serum
serum creatinine
severe acute respiratory syndrome coronavirus 2
significantly higher
survival
systemic inflammation
total bilirubin
while
[DOI] 10.1002/jgh3.12645 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1002/jgh3.12645 PMC 바로가기 [Article Type] Original Article
Prevalence and Genetic Diversity of HAV and HBV Viruses among Jaundice Patients at Coast General Hospital, Mombasa County, Kenya
Original Article
[키워드] genetic diversity
HAV
HBV
jaundice
Prevalence
[DOI] 10.21315/mjms2021.28.3.5 PMC 바로가기 [Article Type] Original Article
[DOI] 10.21315/mjms2021.28.3.5 PMC 바로가기 [Article Type] Original Article
Case Report: Liver Cysts and SARS-CoV-2: No Evidence of Virus in Cystic Fluid
Surgery
[키워드] abdominal pain
acute respiratory syndrome
addition
caused
clinical manifestation
Contamination
coronavirus
CoV-2
COVID-19
COVID-19 virus
cyst
Cystic
dysfunction
Evidence
evidence of
fenestration cyst
Hospital admission
impairment
Infection
jaundice
liver
liver benign disease
liver cyst infection
liver tissue
Mild
nasal swab
non-specific
organ function
outbreak
pandemic
Patient
pharyngeal
Pneumonia
polymerase chain
resulting
SARS-CoV-2
SARS-COV-2 infection
severe pneumonia
Spread
Swab test
Symptom
symptomatic
viral clearance
Viral load
Viral reservoir
[DOI] 10.3389/fsurg.2021.677889 PMC 바로가기 [Article Type] Surgery
[DOI] 10.3389/fsurg.2021.677889 PMC 바로가기 [Article Type] Surgery
Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial
입원 중인 COVID-19 환자의 회복기 혈장 사용의 안전성과 효능을 평가하기 위한 무작위 임상 시험(PERUCONPLASMA): 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
ABO blood type
Acute coronary syndrome
administration
Adverse reaction
Adverse reactions
aliquot
Aliquots
All participants
allocation
anaphylaxis
antibody
Antigen
assessment
Bilirubin
Blinding
block
blocks
blood gas
blood gas analysis
blood type
C-reactive protein
calculated
Capacity
carried
case report form
clinical
clinical trial
clinical trials
Coagulation
Coma
completion
confidence level
congestive heart failure
contraindication
control group
convalescent plasma
coronary syndrome
COVID-19
COVID-19 disease
COVID-19 pneumonia
creatinine
Critical
Critical disease
CRP
current
D-dimer
decrease
defined
detect
Diagnosis
dialysis
disease
Disseminated intravascular coagulation
dissemination
Donor
donors
drop
Duration
Dynamics
eCRF
Efficacy
electronic case report form
element
eligible
enrolled
enrolment
etiology
evaluate
evaluated
events
Evolution
exclusion criteria
expected
experimental group
exploratory
failure
following
gas analysis
hemodynamic instability
hemorrhage
hospital
hospital discharge
Hospitalization
Hospitalized
hospitalized patient
hospitalized patients
Hypothesis
Hypoxemia
ICU
IIb
in-hospital mortality
Inclusion
Infarction
Inflammatory
information
Informed consent
intensive care
intensive care unit
Intervention
intracranial hemorrhage
intravascular coagulation
Invasive mechanical ventilation
investigator
investigators
jaundice
Laboratory
laboratory confirmation
Laboratory test
Lactate
lactate dehydrogenase
Length
less
Local
lymphocyte
male
marker
Mechanical
mechanical ventilation
mmHg
molecular
Mortality
multi-organ failure
Myocardial infarction
Neutralizing antibodies
number
objective
occur
Older
open
open label
outcome
oxygen
Oxygen requirement
oxygen saturation
PaO
participant
Patient
performed
plasma
Platelets
Pneumonia
power
power of 80%
previous diagnosis
Probability
protocol
Public Hospital
public hospitals
quantification
randomization
Randomized
Randomized controlled trial
rationale
receive
reduce
reducing
reduction
Registered
resolution of symptom
respiratory
respiratory rate
routine clinical practice
Safe
Safety
Sample size
SARS-COV-2 infection
score
Secondary objectives
serious adverse reaction
Serious adverse reactions
serologic
serum
serum creatinine
severe COVID-19
Severe COVID-19 pneumonia
severe disease
SOFA
specific type
standard treatment
standard treatment alone
statistical analysis
Study protocol
Stupor
subject
supplementary material
Total
total bilirubin
transfusion
treatment arm
Trial
uncontrolled
vasopressors
Ventilation
website
with COVID-19
[DOI] 10.1186/s13063-021-05189-6 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05189-6 PMC 바로가기 [Article Type] Letter